- Pharmaceutical companies
- Europe
- Italy
- Jazz Pharmaceuticals
Jazz Pharmaceuticals in Italy
Web: https://www.jazzpharma.com/
Address:
-
Gentium S.P.A. Piazza XX Settembre, 2 22079 Villa Guardia CO Italy
Phone: +39 031 537 3200
Other Jazz Pharmaceuticals's locations around the world
Clinical Trials sponsored by Jazz Pharmaceuticals
-
Jazz PharmaceuticalsRekrutteringTuberøs sklerose kompleks assosiert nevropsykiatrisk sykdomForente stater, Storbritannia, Polen
-
Jazz PharmaceuticalsRekrutteringParkinsons sykdom | TremorForente stater, Spania, Tyskland, Polen
-
Jazz PharmaceuticalsRekrutteringSolid svulst | Metastatisk kreft | Avansert kreftForente stater
-
Jazz PharmaceuticalsRekrutteringTuberøs sklerosekompleks | Dravet syndrom | Lennox Gastaut syndromForente stater
-
Jazz PharmaceuticalsRekruttering
-
Jazz PharmaceuticalsAktiv, ikke rekrutterendeHER2-uttrykkende gastrointestinale kreftformer, inkludert gastroøsofagealt adenokarsinom, galleveiskreft og kolorektal kreftForente stater, Korea, Republikken, Chile, Canada
-
Jazz PharmaceuticalsAktiv, ikke rekrutterendeHER2-uttrykkende kreftForente stater, Canada, Korea, Republikken
-
Jazz PharmaceuticalsFullførtLurbinectedin monoterapi hos deltakere med avanserte eller metastatiske solide svulster (EMERGE-201)Avansert solid svulst | Metastatisk solid svulst | Urothelial kreft | Dårlig differensierte nevroendokrine karsinomer | Homolog rekombinasjon mangelfull-positive maligniteter AgnostiskForente stater
-
Jazz PharmaceuticalsAvsluttetSpastisitet med multippel skleroseSpania, Forente stater, Storbritannia, Tsjekkia, Polen
-
Jazz PharmaceuticalsAktiv, ikke rekrutterende
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients. We are focused on developing life-changing medicines for people with serious diseases — often with limited or no options — so they can live their lives more fully. By transforming biopharmaceutical discoveries into novel medicines, we are working to give people around the world the opportunity to redefine what’s possible – to make the “small wins” big again. Through continued investment in an evolving and growing research and development focus, we seek solutions for rare or complex diseases, and ensure those solutions are available for the often-overlooked patients who need them. Our approach has allowed us to shepherd new medicines to market – from late-stage discovery through clinical development and regulatory approval. All of these advancements are a reflection of our continued investment in an evolving and growing research and development focus.